Volume 30, Number 9—September 2024
EIN Research Letter
Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United States
Jeremy A.W. Gold
, Kaitlin Benedict, Shawn R. Lockhart, Caitlyn Lutfy, Meghan Lyman, Dallas J. Smith, Philip M. Polgreen, and Susan E. Beekmann
, Kaitlin Benedict, Shawn R. Lockhart, Caitlyn Lutfy, Meghan Lyman, Dallas J. Smith, Philip M. Polgreen, and Susan E. Beekmann
Table
Survey regarding 158 infectious diseases clinicians’ awareness of antifungal-resistant dermatophyte infections and access to laboratory testing, United States, 2023
| Survey query | No. (%) respondents |
|---|---|
| Primary setting of clinical practice | |
| University hospital | 75 (47) |
| Community hospital | 26 (16) |
| Non-university teaching hospital | 19 (12) |
| Veterans Affairs hospital or Department of Defense | 13 (8) |
| Outpatient setting only | 8 (5) |
| Free-standing children’s hospital | 5 (3) |
| City, county, or public hospital | 4 (3) |
| Other | 4 (3) |
| Question not answered |
4 (3) |
| Type of clinical practice | |
| Adult infectious diseases physician | 126 (80) |
| Pediatric infectious diseases physician | 19 (12) |
| Pharmacist | 6 (4) |
| Nurse practitioner, physician assistant, or physician associate | 2 (1) |
| Other | 4 (3) |
| Question not answered |
1 (1) |
| How did you hear about the issue of antifungal-resistant dermatophyte infections? (select all that apply) | |
| I had not previously heard of this issue | 55 (35) |
| Answers among those who had heard of this issue, n = 103 | |
| Emerging Infections Network emails | 60 (58) |
| CDC webpage or Morbidity and Mortality Weekly Report | 46 (45) |
| Scientific publication | 28 (27) |
| News reports | 18 (17) |
| From clinical colleagues | 18 (17) |
| Clinician education website (e.g., Doximity and Medscape) | 6 (6) |
| Point-of-care medical resource (e.g., UpToDate) | 4 (4) |
| Social media | 2 (2) |
| Other |
6 (6) |
| In the past year, I have seen or consulted on a patient with a dermatophyte infection that was potentially resistant to treatment or concerning for resistance | |
| Yes | 27 (17) |
| No | 119 (75) |
| Unknown |
12 (8) |
| If I saw a patient with a potentially resistant dermatophyte infection, I would be able to obtain laboratory testing to determine the species | |
| Yes | 83 (53) |
| No | 26 (16) |
| Unknown |
49 (31) |
| I would be able to obtain testing to determine if a dermatophyte is resistant to antifungals | |
| Yes | 62 (39) |
| No | 25 (16) |
| Unknown | 71 (45) |
Page created: July 30, 2024
Page updated: August 21, 2024
Page reviewed: August 21, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.